Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 819

1.

Biomarkers of fungal infection: Expert opinion on the current situation.

Bouza E, Almirante B, García Rodríguez J, Garnacho-Montero J, Salavert M, Muñoz P, Sanguinetti M.

Rev Esp Quimioter. 2019 Nov 14. pii: bouza14nov2019. [Epub ahead of print] Review.

PMID:
31729203
2.

Clinical Relevance and Prognostic Value of Persistently Negative (1,3)-β-D-Glucan in Adults With Candidemia: A 5-year Experience in a Tertiary Hospital.

Agnelli C, Bouza E, Del Carmen Martínez-Jiménez M, Navarro R, Valerio M, Machado M, Guinea J, Sánchez-Carrillo C, Alonso R, Muñoz P.

Clin Infect Dis. 2019 Jun 27. pii: ciz555. doi: 10.1093/cid/ciz555. [Epub ahead of print]

PMID:
31680136
3.

Colonization of the nasal airways by Staphylococcus aureus on admission to a major heart surgery operating room: A real-world experience.

Bouza E, Burillo A, de Egea V, Hortal J, Barrio JM, Vicente T, Muñoz P, Pérez-Granda MJ.

Enferm Infecc Microbiol Clin. 2019 Oct 23. pii: S0213-005X(19)30228-9. doi: 10.1016/j.eimc.2019.07.013. [Epub ahead of print] English, Spanish.

PMID:
31668380
4.

Reply to Giacobbe, Berruti and Mikulska.

Agnelli C, Valerio M, Bouza E, Muñoz P.

Clin Infect Dis. 2019 Oct 29. pii: ciz1055. doi: 10.1093/cid/ciz1055. [Epub ahead of print] No abstract available.

PMID:
31665248
5.

Risk stratification for multidrug-resistant Gram-negative infections in ICU patients.

Burillo A, Muñoz P, Bouza E.

Curr Opin Infect Dis. 2019 Dec;32(6):626-637. doi: 10.1097/QCO.0000000000000599.

PMID:
31567570
6.

Prognostic Implications of Influenza Virus Infection in a Cardiac Intensive Care Unit: Potential Impact of a Screening Program.

Muñoz P, Vicent L, Bouza E, Sousa-Casasnovas I, López-Roa P, Juárez M, Eworo A, Devesa C, Bruña V, Catalán P, Fernández-Avilés F, Martínez-Sellés M.

Cardiology. 2019;143(3-4):85-91. doi: 10.1159/000501230. Epub 2019 Sep 12.

PMID:
31514195
7.

Some impressions of the content of the San Francisco ID-Week, in the area of bacterial infection.

Bouza E.

Rev Esp Quimioter. 2019 Sep;32 Suppl 2:22-23. Review. No abstract available.

8.

Prediction of poor outcome in Clostridioides difficile infection: A multicentre external validation of the toxin B amplification cycle.

Reigadas E, Alcalá L, Marín M, Martin A, Muñoz P, Bouza E; Spanish C. difficile Toxin Cycle Study Group.

Anaerobe. 2019 Jul 26:102079. doi: 10.1016/j.anaerobe.2019.102079. [Epub ahead of print]

PMID:
31356959
9.

The situation of vaccines for the prevention of infections in adults: An opinion paper on the situation in Spain.

Bouza E, Ancochea-Bermúdez J, Campins M, Eirós-Bouza JM, Fargas J, García Rojas A, Gracia D, Gutiérrez Sánchez A, Limia A, López JA, Magro MC, Mirada G, Muñoz P, Olier E, Ortiz de Lejarazu R, Urbiztondo L, Palomo E.

Rev Esp Quimioter. 2019 Aug;32(4):333-364. Epub 2019 Jul 26.

10.

Infectious endocarditis caused by Candida glabrata: evidence of in vivo development of echinocandin resistance.

Agnelli C, Guinea J, Valerio M, Escribano P, Bouza E, Muñoz P.

Rev Esp Quimioter. 2019 Aug;32(4):395-397. Epub 2019 Jul 19.

11.

Evaluation of Clostridium difficile Infection with PET/CT Imaging in a Mouse Model.

Cussó L, Reigadas E, Muñoz P, Desco M, Bouza E.

Mol Imaging Biol. 2019 Jul 17. doi: 10.1007/s11307-019-01408-4. [Epub ahead of print]

PMID:
31317298
12.

Clostridioides difficile contamination in the environment of a clinical microbiology laboratory and laboratory workers.

Reigadas E, Vázquez-Cuesta S, Onori R, Villar-Gómara L, Alcalá L, Marín M, Martin A, Muñoz P, Bouza E.

Clin Microbiol Infect. 2019 Jul 5. pii: S1198-743X(19)30378-7. doi: 10.1016/j.cmi.2019.06.027. [Epub ahead of print]

PMID:
31284033
13.

Evaluation of the Alfred™ turbidity monitoring system (Alifax®) following sonication in the diagnosis of central venous catheter colonization.

Alonso B, Latorre MC, Cruces R, Ampuero D, Haces L, Martín-Rabadán P, Sánchez-Carrillo C, Rodríguez B, Bouza E, Muñoz P, Guembe M.

Eur J Clin Microbiol Infect Dis. 2019 Sep;38(9):1737-1742. doi: 10.1007/s10096-019-03606-y. Epub 2019 Jun 17.

PMID:
31209648
14.

Fatal disseminated infection by Gymnascella hyalinospora in a heart transplant recipient.

Agnelli C, Valerio M, Olmedo M, Guinea J, Zatarain-Nicolás E, Del Carmen Martínez-Jiménez M, Alcalá L, Escribano P, Cebollero Presmanes M, Bouza E, Muñoz P, Martín-Rabadán P.

Transpl Infect Dis. 2019 Oct;21(5):e13128. doi: 10.1111/tid.13128. Epub 2019 Jul 16.

PMID:
31206924
15.

Corrigendum: Growth kinetics in Candida spp.: Differences between species and potential impact on antifungal susceptibility testing as described by the EUCAST.

Ángeles Bordallo-Cardona M, Sánchez-Carrillo C, Muñoz P, Bouza E, Escribano P, Guinea J.

Med Mycol. 2019 Feb 19. pii: myy155. doi: 10.1093/mmy/myy155. [Epub ahead of print] No abstract available.

PMID:
30989218
16.

Role of age and comorbidities in mortality of patients with infective endocarditis.

Armiñanzas C, Fariñas-Alvarez C, Zarauza J, Muñoz P, González Ramallo V, Martínez Sellés M, Miró Meda JM, Pericás JM, Goenaga MÁ, Ojeda Burgos G, Rodríguez Álvarez R, Castelo Corral L, Gálvez-Acebal J, Martínez Marcos FJ, Fariñas MC; Spanish Collaboration on Endocarditis — Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en Espana Study Group, Fernández Sánchez F, Noureddine M, Rosas G, de la Torre Lima J, Aramendi J, Bereciartua E, Blanco MJ, Blanco R, Boado MV, Campaña Lázaro M, Crespo A, Goikoetxea J, Iruretagoyena JR, Irurzun Zuazabal J, López-Soria L, Montejo M, Nieto J, Rodrigo D, Rodríguez D, Rodríguez R, Vitoria Y, Voces R, García López MV, Georgieva RI, Ojeda G, Rodríguez Bailón I, Ruiz Morales J, Cuende AM, Echeverría T, Fuerte A, Gaminde E, Goenaga MÁ, Idígoras P, Iribarren JA, Izaguirre Yarza A, Kortajarena Urkola X, Reviejo C, Carrasco R, Climent V, Llamas P, Merino E, Plazas J, Reus S, Álvarez N, Bravo-Ferrer JM, Castelo L, Cuenca J, Llinares P, Miguez Rey E, Rodríguez Mayo M, Sánchez E, Sousa Regueiro D, Martínez FJ, Alonso MDM, Castro B, García Rosado D, Durán MDC, Miguel Gómez MA, Lacalzada J, Nassar I, Plata Ciezar A, Reguera Iglesias JM, Asensi Álvarez V, Costas C, de la Hera J, Fernández Suárez J, Iglesias Fraile L, León Arguero V, López Menéndez J, Mencia Bajo P, Morales C, Moreno Torrico A, Palomo C, Paya Martínez B, Rodríguez Esteban Á, Rodríguez García R, Telenti Asensio M, Almela M, Ambrosioni J, Azqueta M, Brunet M, Bodro M, Cartañá R, Falces C, Fita G, Fuster D, García de la Mària C, Hernández-Meneses M, Llopis Pérez J, Marco F, Miró JM, Moreno A, Nicolás D, Ninot S, Quintana E, Paré C, Pereda D, Pericás JM, Pomar JL, Ramírez J, Rovira I, Sandoval E, Sitges M, Soy D, Téllez A, Tolosana JM, Vidal B, Vila J, Adán I, Bermejo J, Bouza E, Celemín D, Cuerpo Caballero G, Delgado Montero A, Fernández Cruz A, García Mansilla A, García Leoni ME, González Ramallo V, Kestler Hernández M, Hualde AM, Marín M, Martínez-Sellés M, Menárguez MC, Muñoz P, Rincón C, Rodríguez-Abella H, Rodríguez-Créixems M, Pinilla B, Pinto Á, Valerio M, Vázquez P, Verde Moreno E, Antorrena I, Loeches B, Martín Quirós A, Moreno M, Ramírez U, Rial Bastón V, Romero M, Saldaña A, Agüero Balbín J, Amado C, Armiñanzas Castillo C, Arnaiz García A, Cobo Belaustegui M, Fariñas MC, Fariñas-Álvarez C, Gómez Izquierdo R, García I, González-Rico C, Gutiérrez-Cuadra M, Gutiérrez Díez J, Pajarón M, Parra JA, Sarralde A, Teira R, Zarauza J, Domínguez F, García Pavía P, González J, Orden B, Ramos A, Centella T, Hermida JM, Moya JL, Martín-Dávila P, Navas E, Oliva E, Del Río A, Ruiz S, Hidalgo Tenorio C, Almendro Delia M, Araji O, Barquero JM, Calvo Jambrina R, de Cueto M, Gálvez Acebal J, Méndez I, Morales I, López-Cortés LE, de Alarcón A, García E, Haro JL, Lepe JA, López F, Luque R, Alonso LJ, Azcárate P, Azcona Gutiérrez JM, Blanco JR, García-Álvarez L, Oteo JA, Sanz M, de Benito N, Gurguí M, Pacho C, Pericas R, Pons G, Álvarez M, Fernández AL, Martínez A, Prieto A, Regueiro B, Tijeira E, Vega M, Canut Blasco A, Cordo Mollar J, Gainzarain Arana JC, García Uriarte O, Martín López A, Ortiz de Zárate Z, Urturi Matos JA, García Domínguez G, Sánchez-Porto A, Arribas Leal JM, García Vázquez E, Hernández Torres A, Blázquez A, de la Morena Valenzuela G, Alonso Á, Aramburu J, Calvo FE, Moreno Rodríguez A, Tarabini-Castellani P, Heredero Gálvez E, Maicas Bellido C, Largo Pau J, Sepúlveda MA, Toledano Sierra P, Iqbal-Mirza SZ, Cascales Alcolea E, Egea Serrano P, Hernández Roca JJ, Keituqwa Yañez I, Peláez Ballesta A, Soriano V, Moreno Escobar E, Peña Monje A, Sánchez Cabrera V, Vinuesa García D, Arrizabalaga Asenjo M, Cifuentes Luna C, Núñez Morcillo J, Pérez Seco MC, Villoslada Gelabert A, Aured Guallar C, Fernández Abad N, García Mangas P, Matamala Adell M, Palacián Ruiz MP, Porres JC, Alcaraz Vidal B, Cobos Trigueros N, Del Amor Espín MJ, Giner Caro JA, Jiménez Sánchez R, Jimeno Almazán A, Ortín Freire A, Viqueira González M, Pericás Ramis P, Ribas Blanco MÁ, Ruiz de Gopegui Bordes E, Vidal Bonet L, Bellón Munera MC, Escribano Garaizabal E, Tercero Martínez A, Segura Luque JC.

Eur J Intern Med. 2019 Jun;64:63-71. doi: 10.1016/j.ejim.2019.03.006. Epub 2019 Mar 21.

PMID:
30904433
17.

Information on nosocomial infections in the mainstream media: an opinion document.

Bouza E, Alonso S, Asensio A, De Juan G, García Lucio C, Larrosa C, López-Iglesias J, Muñoz P, Sierra R, Perianes J, De la Serna JL, Palomo E, Gracia D.

Rev Esp Quimioter. 2019 Apr;32(2):165-177. Epub 2019 Mar 18.

18.

Is it reasonable to perform Fecal Microbiota Transplantation for recurrent Clostridium difficile Infection in patients with liver cirrhosis?

Olmedo M, Reigadas E, Valerio M, Vázquez-Cuesta S, Pajares JA, Matilla A, Muñoz P, Bouza E.

Rev Esp Quimioter. 2019 Apr;32(2):205-207. Epub 2019 Mar 8.

19.

Whole genome sequencing-based analysis of tuberculosis (TB) in migrants: rapid tools for cross-border surveillance and to distinguish between recent transmission in the host country and new importations.

Abascal E, Pérez-Lago L, Martínez-Lirola M, Chiner-Oms Á, Herranz M, Chaoui I, Comas I, El Messaoudi MD, Cárdenas JAG, Santantón S, Bouza E, García-de-Viedma D.

Euro Surveill. 2019 Jan;24(4). doi: 10.2807/1560-7917.ES.2019.24.4.1800005.

20.

A man from Morocco and chronic hip pain.

Paño JR, Pigrau C, Morte E, Almirante B, Muñoz P, Bouza E.

Rev Esp Quimioter. 2019 Feb;32(1):78-82. Epub 2019 Jan 25.

21.

Persistent Candidemia in adults: underlying causes and clinical significance in the antifungal stewardship era.

Agnelli C, Valerio M, Bouza E, Vena A, Guinea J, Del Carmen Martínez-Jiménez M, Marcos-Zambrano LJ, Escribano P, Muñoz P; COMIC Study Group (Collaborative Group on Mycosis).

Eur J Clin Microbiol Infect Dis. 2019 Mar;38(3):607-614. doi: 10.1007/s10096-019-03477-3. Epub 2019 Jan 24.

PMID:
30680572
22.

Mitral valve repair in infective endocarditis is not inferior to valve replacement: results from a Spanish nationwide prospective registry.

Cuerpo GP, Valerio M, Pedraz A, Rodríguez-Abella H, Mestres CA, Obrador EQ, González-Calle A, Rodríguez Álvarez R, García PM, Bouza E; GAMEs Study Group.

Gen Thorac Cardiovasc Surg. 2019 Jul;67(7):585-593. doi: 10.1007/s11748-019-01063-0. Epub 2019 Jan 21.

PMID:
30666586
23.

Do lower respiratory tract samples contribute to the assessment of carriage of Staphylococcus aureus in patients undergoing mechanical ventilation after major heart surgery?

Bouza E, Burillo A, Munoz P, Valerio M, Barrio JM, Hortal J, Cuerpo G, Perez-Granda MJ.

PLoS One. 2018 Dec 26;13(12):e0207854. doi: 10.1371/journal.pone.0207854. eCollection 2018.

24.

Detection of Echinocandin-Resistant Candida glabrata in Blood Cultures Spiked with Different Percentages of FKS2 Mutants.

Bordallo-Cardona MÁ, Sánchez-Carrillo C, Bouza E, Muñoz P, Escribano P, Guinea J.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e02004-18. doi: 10.1128/AAC.02004-18. Print 2019 Mar.

25.

[Recommendations from a panel of experts on the usefulness of fidaxomicin for the treatment of infections caused by Clostridium difficile].

Bouza E, Cobo J, Almirante B; Grupo de Trabajo CLODIEXPAN.

Rev Esp Quimioter. 2019 Feb;32(1):50-59. Epub 2018 Dec 13. Spanish.

26.

Identification of Porphyromonas isolates from clinical origin using MALDI-TOF Mass Spectrometry.

Zamora-Cintas M, Marín M, Quiroga L, Martínez A, Fernández-Chico MA, Bouza E, Rodríguez-Sánchez B, Alcalá L.

Anaerobe. 2018 Dec;54:197-200. doi: 10.1016/j.anaerobe.2018.06.017. Epub 2018 Jul 2.

PMID:
30541687
27.

T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study-authors' response.

Bouza E, Vena A, Munoz P; T2MadRid study group .

J Antimicrob Chemother. 2019 Feb 1;74(2):533-534. doi: 10.1093/jac/dky460. No abstract available.

PMID:
30476190
28.

Severe bacterial non-AIDS infections in HIV women.

Galindo García MJ, Kestler M, Muñoz P, Bouza E.

Rev Esp Quimioter. 2018 Dec;31(6):546-549. Epub 2018 Nov 7.

29.

Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE).

Vehreschild MJGT, Taori S, Goldenberg SD, Thalhammer F, Bouza E, van Oene J, Wetherill G, Georgopali A.

Eur J Clin Microbiol Infect Dis. 2019 Jan;38(1):199. doi: 10.1007/s10096-018-3410-8.

30.

MSH2 Gene Point Mutations Are Not Antifungal Resistance Markers in Candida glabrata.

Bordallo-Cardona MÁ, Agnelli C, Gómez-Nuñez A, Sánchez-Carrillo C, Bouza E, Muñoz P, Escribano P, Guinea J.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01876-18. doi: 10.1128/AAC.01876-18. Print 2019 Jan.

31.

First isolation of Skermanella aerolata from a human sample.

Onori R, Marín M, Rodríguez-Sánchez B, Oliver C, Muñoz P, Bouza E, Alcalá L.

Rev Esp Quimioter. 2018 Dec;31(6):552-553. Epub 2018 Oct 22.

32.

Growth kinetics in Candida spp.: Differences between species and potential impact on antifungal susceptibility testing as described by the EUCAST.

Bordallo-Cardona MÁ, Sánchez-Carrillo C, Muñoz P, Bouza E, Escribano P, Guinea J.

Med Mycol. 2018 Oct 18. doi: 10.1093/mmy/myy097. [Epub ahead of print]

PMID:
30339238
33.

Current use of daptomycin and systematic therapeutic drug monitoring: Clinical experience in a tertiary care institution.

Galar A, Muñoz P, Valerio M, Cercenado E, García-González X, Burillo A, Sánchez-Somolinos M, Juárez M, Verde E, Bouza E.

Int J Antimicrob Agents. 2019 Jan;53(1):40-48. doi: 10.1016/j.ijantimicag.2018.09.015. Epub 2018 Sep 19.

PMID:
30243587
34.

Fast track SSTI management program based on a rapid molecular test (GeneXpert® MRSA/SA SSTI) and antimicrobial stewardship.

Bouza E, Onori R, Semiglia-Chong MA, Álvarez-Uría A, Alcalá L, Burillo A.

J Microbiol Immunol Infect. 2018 Aug 31. pii: S1684-1182(18)30338-4. doi: 10.1016/j.jmii.2018.07.008. [Epub ahead of print]

35.

Fecal microbiota transplantation for recurrent Clostridium difficile infection: Experience, protocol, and results.

Reigadas E, Olmedo M, Valerio M, Vázquez-Cuesta S, Alcalá L, Marín M, Muñoz P, Bouza E.

Rev Esp Quimioter. 2018 Oct;31(5):411-418. Epub 2018 Sep 14.

36.

Assessment of the anti-biofilm effect of micafungin in an animal model of catheter-related candidemia.

Salinas B, Guembe M, Cussó L, Kestler M, Guinea J, Desco M, Muñoz P, Bouza E.

Med Mycol. 2019 Jun 1;57(4):496-503. doi: 10.1093/mmy/myy065.

PMID:
30212901
37.

Fluconazole resistance is not a predictor of poor outcome in patients with cryptococcosis.

Vena A, Muñoz P, Guinea J, Escribano P, Peláez T, Valerio M, Bonache F, Gago S, Álvarez-Uría A, Bouza E.

Mycoses. 2019 May;62(5):441-449. doi: 10.1111/myc.12847. Epub 2019 Mar 13.

PMID:
30184276
38.

Fast update of undetected Mycobacterium chimaera infections to reveal unsuspected cases.

Acosta F, Pérez-Lago L, Ruiz Serrano MJ, Marín M, Kohl TA, Lozano N, Niemann S, Valerio M, Olmedo M, Pérez-Granda MJ, Pérez Pérez MR, Bouza E, Muñoz P, García de Viedma D.

J Hosp Infect. 2018 Dec;100(4):451-455. doi: 10.1016/j.jhin.2018.08.018. Epub 2018 Sep 1.

PMID:
30179655
39.

Role of the Clinical Microbiology Laboratory in Antimicrobial Stewardship.

Bouza E, Muñoz P, Burillo A.

Med Clin North Am. 2018 Sep;102(5):883-898. doi: 10.1016/j.mcna.2018.05.003. Epub 2018 Jul 14. Review.

PMID:
30126578
40.

Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE).

Vehreschild MJGT, Taori S, Goldenberg SD, Thalhammer F, Bouza E, van Oene J, Wetherill G, Georgopali A.

Eur J Clin Microbiol Infect Dis. 2018 Nov;37(11):2097-2106. doi: 10.1007/s10096-018-3344-1. Epub 2018 Aug 11. Erratum in: Eur J Clin Microbiol Infect Dis. 2019 Jan;38(1):199.

41.

Donor-derived invasive aspergillosis after kidney transplant.

Valerio M, Machado M, Cedeño S, Rodríguez ML, Anaya F, Vena A, Guinea J, Escribano P, Bouza E, Muñoz P.

Med Mycol Case Rep. 2018 Jul 17;22:24-26. doi: 10.1016/j.mmcr.2018.07.004. eCollection 2018 Dec.

42.

Repeated antifungal use audits are essential for selecting the targets for intervention in antifungal stewardship.

Valerio M, Vena A, Rodríguez-González CG, de Vega EC, Mateos M, Sanjurjo M, Bouza E, Muñoz P; COMIC Study Group (Collaborative Group on Mycoses).

Eur J Clin Microbiol Infect Dis. 2018 Oct;37(10):1993-2000. doi: 10.1007/s10096-018-3335-2. Epub 2018 Aug 4.

PMID:
30078143
43.

Direct genotyping of Mycobacterium tuberculosis from Xpert® MTB/RIF remnants.

Mambuque ET, Abascal E, Venter R, Bulo H, Bouza E, Theron G, García-Basteiro AL, García-de-Viedma D.

Tuberculosis (Edinb). 2018 Jul;111:202-206. doi: 10.1016/j.tube.2018.05.008. Epub 2018 May 15.

PMID:
30029910
44.

Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect.

Marcos-Zambrano LJ, Gómez A, Sánchez-Carrillo C, Bouza E, Muñoz P, Escribano P, Guinea J.

Clin Microbiol Infect. 2018 Dec;24(12):1343.e1-1343.e4. doi: 10.1016/j.cmi.2018.07.006. Epub 2018 Jul 17.

PMID:
30025834
45.

Correction to: Attitudes of physicians from 10 European countries on adherence and how treatment modalities in ABSSSI affect adherence: results from a Delphi survey.

Stargardt T, Eckmann C, Bouza E, Rossolini GM, Grossi PA.

Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1619. doi: 10.1007/s10096-018-3310-y.

46.

Estimation of missed bloodstream infections without the third blood culture set: a retrospective observational single-centre study.

Collazos-Blanco A, Pérez-García F, Sánchez-Carrillo C, de Egea V, Muñoz P, Bouza E.

Clin Microbiol Infect. 2019 Apr;25(4):469-473. doi: 10.1016/j.cmi.2018.06.024. Epub 2018 Jun 28.

PMID:
29964233
47.

A patient with a rapidly lethal pneumonia after a visit to a touristic area in rural Leon (Spain).

Valerio M, López-Medrano F, Regalado-Artamendi I, Muñoz P, Aguado JM, Bouza E.

Rev Esp Quimioter. 2018 Aug;31(4):367-373. Epub 2018 Jun 28. No abstract available.

48.

A new cause of false positive voriconazole levels: Watch your collection tubes!

Burillo A, Gómez-López A, Escribano P, Galar A, Salinas B, Díaz-Pérez N, Muñoz P, Bouza E.

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Aug 15;1092:328-331. doi: 10.1016/j.jchromb.2018.06.022. Epub 2018 Jun 13.

PMID:
29936368
49.

Identification of Nocardia species from clinical isolates using MALDI-TOF mass spectrometry.

Marín M, Ruiz A, Iglesias C, Quiroga L, Cercenado E, Martín-Rabadán P, Bouza E, Rodríguez-Sánchez B.

Clin Microbiol Infect. 2018 Dec;24(12):1342.e5-1342.e8. doi: 10.1016/j.cmi.2018.06.014. Epub 2018 Jun 20.

PMID:
29933050
50.

Attitudes of physicians from 10 European countries on adherence and how treatment modalities in ABSSSI affect adherence: results from a Delphi survey.

Stargardt T, Eckmann C, Bouza E, Rossolini GM, Grossi PA.

Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1611-1618. doi: 10.1007/s10096-018-3264-0. Epub 2018 Jun 6. Erratum in: Eur J Clin Microbiol Infect Dis. 2018 Jul 12;:.

Supplemental Content

Support Center